Friday, February 3, 2023

< + > Taking A Closer Look At Molnupiravir. Is Continued Use Justified?

Research suggests molnupiravir may supercharge new SARS-CoV-2 variants.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Bonus Features – March 29, 2026 – 57% of execs say AI-based clinical tools are their top tech initiative, 57% of patients say AI isn’t mature enough for docs to trust it, plus 32 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...